Clinical characterization and founder effect analysis in Chinese amyotrophic lateral sclerosis patients with SOD1 common variants

Objective In the Asian population, SOD1 variants are the most common cause of amyotrophic lateral sclerosis (ALS). To date, more than 200 variants have been reported in SOD1. This study aimed to summarize the genotype–phenotype correlation and determine whether the patients carrying common variants...

Full description

Bibliographic Details
Published in:	Annals of Medicine
Main Authors:	Pei-Shan Wang, Xin-Xia Yang, Qiao Wei, Yong-Ting Lv, Zhi-Ying Wu, Hong-Fu Li
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Subjects:	Amyotrophic lateral sclerosis SOD1 Chinese common variants founder effect SOD1 aggregation
Online Access:	https://www.tandfonline.com/doi/10.1080/07853890.2024.2407522

Similar Items

Variability in SOD1-associated amyotrophic lateral sclerosis: geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications
by: Miaodan Huang, et al.
Published: (2024-05-01)

FAIM Opposes Aggregation of Mutant SOD1 That Typifies Some Forms of Familial Amyotrophic Lateral Sclerosis
by: Hiroaki Kaku, et al.
Published: (2020-02-01)

Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues
by: Mitsunori Watanabe, et al.
Published: (2001-12-01)

An Advancements In Treatment Of Amyotrophic Lateral Sclerosis (ALS)
by: Weronika Ożóg, et al.
Published: (2025-06-01)

Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials
by: Syed I. Khalid, et al.
Published: (2017-09-01)

Young-Onset Amyotrophic Lateral Sclerosis: Genetic Structure and Phenotypic Features
by: Denis V. Shevchuk, et al.
Published: (2025-06-01)

Inhibition of SOD1 trimerization is a novel drug target for ALS disease
by: Tae-Gyun Woo, et al.
Published: (2025-05-01)

Haplotype Analysis of the First A4V-SOD1 Spanish Family: Two Separate Founders or a Single Common Founder?
by: Cecilia Garcia, et al.
Published: (2019-11-01)

A polytherapy approach demonstrates therapeutic efficacy for the treatment of SOD1 associated amyotrophic lateral sclerosisResearch in context
by: Jeremy S. Lum, et al.
Published: (2025-05-01)

Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients
by: Daisy Sproviero, et al.
Published: (2018-07-01)

Mahogunin ring finger 1 confers cytoprotection against mutant SOD1 aggresomes and is defective in an ALS mouse model
by: Deepak Chhangani, et al.
Published: (2016-02-01)

Specific analysis of SOD1 enzymatic activity in CSF from ALS patients with and without SOD1 mutations
by: Laura Leykam, et al.
Published: (2024-11-01)

Case report: Flail leg syndrome in familial amyotrophic lateral sclerosis with L144S SOD1 mutation
by: Ewa Zapalska, et al.
Published: (2023-03-01)

Invertebrate genetic models of amyotrophic lateral sclerosis
by: LiJun Zhou, et al.
Published: (2024-03-01)

Amyloidogenic regions in beta-strands II and III modulate the aggregation and toxicity of SOD1 in living cells
by: Luke McAlary, et al.
Published: (2024-06-01)

Compassionate Use of the ROCK Inhibitor Fasudil in Three Patients With Amyotrophic Lateral Sclerosis
by: Jan C. Koch, et al.
Published: (2020-03-01)

Presymptomatic genetic counseling in amyotrophic lateral sclerosis
by: Yu. A. Shpilyukova, et al.
Published: (2018-01-01)

Clinical and genetic study of a Chinese family affected by both amyotrophic lateral sclerosis and autosomal dominant polycystic kidney disease
by: Shirong Li, et al.
Published: (2022-10-01)

Free fatty acids support oligodendrocyte survival in a mouse model of amyotrophic lateral sclerosis
by: Takashi Maruyama, et al.
Published: (2023-05-01)

Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential
by: Justin You, et al.
Published: (2023-10-01)

The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis
by: Lijun Wang, et al.
Published: (2009-08-01)

Protective effects of intrathecal injection of AAV9-RabGGTB-GFP+ in SOD1G93A mice
by: Tianchu Gao, et al.
Published: (2023-03-01)

Circulating Cytokines Could Not Be Good Prognostic Biomarkers in a Mouse Model of Amyotrophic Lateral Sclerosis
by: Laura Moreno-Martínez, et al.
Published: (2019-04-01)

Difficulties in diagnosing amyotrophic lateral sclerosis in a HIV-Positive Patient
by: T. M. Alekseeva, et al.
Published: (2018-12-01)

NRF2 activation suppresses motor neuron ferroptosis induced by the SOD1G93A mutation and exerts neuroprotection in amyotrophic lateral sclerosis
by: Biying Yang, et al.
Published: (2023-08-01)

Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS
by: Maria Tsekrekou, et al.
Published: (2024-05-01)

Implications of miRNAs dysregulation in amyotrophic lateral sclerosis: Challenging for clinical applications
by: Yuka Koike, et al.
Published: (2023-02-01)

LncRNAs Associated with Neuronal Development and Oncogenesis Are Deregulated in SOD1-G93A Murine Model of Amyotrophic Lateral Sclerosis
by: Federica Rey, et al.
Published: (2021-07-01)

Familial amyotrophic lateral sclerosis: a report of two cases
by: Zeng LI, et al.
Published: (2022-06-01)

P2X7 antagonism using Brilliant Blue G reduces body weight loss and prolongs survival in female SOD1G93A amyotrophic lateral sclerosis mice
by: Rachael Bartlett, et al.
Published: (2017-03-01)

Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients
by: Elisa Perciballi, et al.
Published: (2022-04-01)

Parkin is a disease modifier in the mutant SOD1 mouse model of ALS
by: Gloria M Palomo, et al.
Published: (2018-08-01)

Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis
by: Erika L.F. Holzbaur, et al.
Published: (2006-09-01)

Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis
by: Florent Laferriere, et al.
Published: (2015-01-01)

CD4 T-cell aging exacerbates neuroinflammation in a late-onset mouse model of amyotrophic lateral sclerosis
by: Shir Zaccai, et al.
Published: (2024-01-01)

Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history
by: Lu Tang, et al.
Published: (2019-01-01)

Prognostic role of ‘prion-like propagation’ in SOD1-linked familial ALS: an alternative view
by: Keizo eSugaya, et al.
Published: (2014-10-01)

Identification of TARDBP Gly298Ser as a founder mutation for amyotrophic lateral sclerosis in Southern China
by: Fanxi Xu, et al.
Published: (2022-08-01)

Genetics of familial amyotrophic lateral sclerosis
by: A. V. Savinova, et al.
Published: (2021-10-01)

The genetic puzzle of a SOD1-patient with ocular ptosis and a motor neuron disease: a case report
by: Veria Vacchiano, et al.
Published: (2023-12-01)